Skip to main content

Advertisement

SpringerLink
Log in

World-wide development of antibiotic resistance in pneumococci

  • Review
  • Published:
European Journal of Clinical Microbiology Aims and scope Submit manuscript

Abstract

Antibiotic-resistant pneumococci, especially penicillin-resistant strains, are being increasingly isolated. Pneumococci with intermediate penicillin-resistance (MIC).1–1.0 μg/ml) have been reported from many parts of the world over the past two decades, and highly resistant strains (penicillin MICs⩾2 μg/ml) have also appeared. Infection may be acquired in the hospital or community, and nosocomial outbreaks may occur which require control measures to limit organism spread. Most infections occur in children with diminished host responses. Disease caused by pneumococci with intermediate penicillin-resistance may be treated with high doses of penicillin, but disease caused by highly resistant strains, especially meningitis, may require alternative therapy. Pneumococci resistant to sulfonamides, tetracyclines, erythromycin, lincomycin, clindamycin, chloramphenicol, aminoglycosides and rifampin have also appeared. Strains resistant to all the above-mentioned agents, including allβ-lactam antibiotics tested, have bee.n reported from South Africa and Spain. Alternative therapy for resistant strains may include vancomycin, cefotaxime, cefoperazone, ceftriaxone and imipenem. Pneumococci isolated from sites suggestive of infection, especially blood and cerebrospinal fluid, should be routinely tested for penicillin-susceptibility.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Frisch, A. W., Price, A. E., Myers, G. B.: Type VIII pneumococcus: development of sulfadiazine resistance, transmission by cross-infection, and persistence in carriers. Annals of Internal Medicine 1943, 18: 271–278.

    Google Scholar 

  2. Hamburger, M., Schmidt, L. H., Sesler, C. L., Ruegsegger, J. M., Grupen, E. S.: The occurrence of sulfonamide-resistant pneumococci in clinical practice. Journal of Infectious Diseases 1943, 73: 12–30.

    Google Scholar 

  3. Evans, W., Hansman, D.: Tetracycline-resistant pneumococci. Lancet 1963, i: 451.

    Google Scholar 

  4. Turner, G. C.: Tetracycline-resistant pneumococci in a general hospital. Lancet 1963, ii: 1292–1295.

    Google Scholar 

  5. Coffey, J. D., Booth, H. N.: Otitis media caused by oxytetracycline resistant pneumococci: a case report. Journal of the Mississippi State Medical Association 1965, 6: 219–220.

    Google Scholar 

  6. Schaedler, R. W., Choppin, P. W., Zabriskie, J. B.: Pneumonia caused by tetracycline-resistant pneumococci. New England Journal of Medicine 1964, 270: 127–129.

    PubMed  Google Scholar 

  7. Ragsdale, A. R., Sanfoid, J. P.: Prevalence of tetracycline-resistantDiplococcus pneumonias. Antimicrobial Agents and Chemotherapy 1964, 4: 164–167.

    Google Scholar 

  8. Schaffner, W., Schreiber, W. M., Koenig, M. G.: Fatal pneumonia due to a tetracycline-resistant pneumococcus. New England Journal of Medicine 1966, 274: 451–452.

    PubMed  Google Scholar 

  9. Pulverer, G.: Tetracyclin-Resistenz bei beta-hämolysierenden Streptokokken und bei Pneumokokken. Deutsche medizinische Wochenschrift 1967, 92: 1608–1612.

    PubMed  Google Scholar 

  10. Hansman, D., Andrews, G.: Hospital infection with pneumococci resistant to tetracycline. Medical Journal of Australia 1967, i: 498–501.

    Google Scholar 

  11. Percival, A., Armstrong, E. C., Turner, G. C.: Increased incidence of tetracycline-resistant pneumococci in Liverpool in 1968. Lancet 1969, i: 998–1000.

    Google Scholar 

  12. Bizzozero, O. J., Andriole, V. T.: Tetracycline-resistant pneumococcal infection. Archives of Internal Medicine 1969, 123: 388–393.

    PubMed  Google Scholar 

  13. Cybulska, J., Jeljaszewicz, J., Lund, E., Munksgaard, A.: Prevalence of types ofDiplococcus pneumoniae and their susceptibility to 30 antibiotics. Chemotherapy 1970, 15: 304–316.

    PubMed  Google Scholar 

  14. Gopalakrishna, K. V., Lerner, P. I.: Tetracycline-resistant pneumococci. Increasing incidence and cross resistance to newer tetracyclines. American Review of Respiratory Disease 1973, 108: 1007–1010.

    PubMed  Google Scholar 

  15. Ad-Hoc Study Group: Tetracycline resistance in pneumococci and group A streptococci. British Medical Journal 1977, i: 131–133.

    Google Scholar 

  16. Goldstein, F. W., Dang Van, A., Bouanchaud, D. H., Acar, J. F.: Evolution de la résistance aux antibiotiques des pneumocoques et répartition de leurs types capsulaires. Pathologie et Biologie 1978, 26: 173–180.

    PubMed  Google Scholar 

  17. Dixon, J. M. S.: Pneumococcus resistant to erythromycin and lincomycin. Lancet 1967, i: 573.

    Google Scholar 

  18. Kislak, J. W.: Type 6 pneumococcus resistant to erythromycin and lincomycin. New England Journal of Medicine 1967, 276: 852.

    PubMed  Google Scholar 

  19. Cooper, R. G., Rischbieth, H. G., Vesey, B.: Anerythromycin-resistant pneumococcus. Medical Journal of Australia 1968, i: 1131.

    Google Scholar 

  20. Parker, R. H., Davison, R., Paterson, P. Y., Madden, G. M.: Erythromycin-resistant pneumococcal osteomyelitis. American Journal of Medicine 1970, 48: 132–136.

    PubMed  Google Scholar 

  21. Champion, L. A. A., Wald, E. R., Luddy, R. E., Schwarte, A. D.:Streptococcus pneumoniae resistant to erythromycin and clindamycin. Journal of Pediatrics 1978, 92: 505–506.

    PubMed  Google Scholar 

  22. Dixon, J. M. S., Lipinski, A. E.: Pneumococci resistant to erythromycin. Canadian Medical Association Journal 1978, 119: 1044–1046.

    PubMed  Google Scholar 

  23. Howatd, A. J., Hince, C. J., Williams, J. D.: Antibiotic resistance inStreptococcus pneumoniae andHaemophilus influenzae. Report of a study group on bacterial resistance. British Medical Journal 1978, i: 1657–1660.

    Google Scholar 

  24. Hansman, D.: Chloramphenicol-resistant pneumococci in West Africa. Lancet 1978, i: 1102.

    Google Scholar 

  25. Dang-Van, A., Tiraby, G., Acar, J. F., Shaw, W. V., Bouanchaud, D. H.: Chloramphenicol resistance inStreptococcus pneumoniae; enzymatic acetylation and possible plasmid linkage. Antimicrobial Agents and Chemotherapy 1978, 13: 577–583.

    PubMed  Google Scholar 

  26. Ward, J.: Antibiotic-resistantStreptococcus pneumoniae: clinical and epidemiological aspects. Reviews of Infectious Diseases 1981, 3: 254–266.

    PubMed  Google Scholar 

  27. Hansman, D., Bullen, M. M.: A resistant pneumococcus. Lancet 1967, ii: 264–265.

    Google Scholar 

  28. Hansman, D., Glasgow, H., Sturt, J., Devitt, L., Douglas, R.: Increased resistance to penicillin of pneumococci isolated from man. New England Journal of Medicine 1971, 284: 175–177.

    PubMed  Google Scholar 

  29. Hansman, D., Glasgow, H. N., Sturt, J., Devitt, L., Douglas, R. M.: Pneumococci resistant to penicillin. Nature 1971, 230: 407.

    PubMed  Google Scholar 

  30. Hansman, D.: Type distribution and antibiotic sensitivity of pneumococci from carriers in Kiriwina, Trobriand Islands (New Guinea). Medical Journal of Australia 1972, ii: 771–773.

    Google Scholar 

  31. Hansman, D.: Antibiotic sensitivity pattern of pneumococci relatively insensitive to penicillin and cephalosporin antibiotics. Medical Journal of Australia 1975, ii: 740–742.

    Google Scholar 

  32. Hansman, D., Devitt, L., Miles, H., Riley, I.: Pneumococci relatively insensitive to penicillin in Australia and New Guinea. Medical Journal of Australia 1974, ii: 353–356.

    Google Scholar 

  33. Devitt, L., Riley, I., Hansman, D.: Human infection caused by penicillin-insensitive pneumococci. Medical Journal of Australia 1977, i: 586–588.

    Google Scholar 

  34. Hansman, D.: Penicillin-insensitive pneumococci in Australia and New Guinea: a progress report. Medical Journal of Australia 1978, ii: 295–296.

    Google Scholar 

  35. Hansman, D.: Multiple drug resistance inPneumococcus (Diplococcus pneumoniae). In: Siegenthaler, W., Lüthy, R. (ed.): Current chemotherapy. Proceedings of the 10th International Congress of Chemotherapy, Volume I. American Society for Microbiology, Washington, DC, 1978, p. 540–543.

    Google Scholar 

  36. Gratten, M., Naraqi, S., Hansman, D.: High prevalence of penicillin-insensitive pneumococci in Port Moresby, Papua New Guinea. Lancet 1980, ii: 192–195.

    Google Scholar 

  37. Naraqi, S., Kirkpatrick, G. P., Kabins, S.: Relapsing pneumococcal meningitis: isolation of an organism with decreased susceptibility to penicillin G. Journal of Pediatrics 1974, 85: 671–673.

    PubMed  Google Scholar 

  38. Howes, V. J., Mitchell, R. G.: Meningitis due to relatively penicillin-resistant pneumococcus. British Medical Journal 1976, i: 996.

    Google Scholar 

  39. Parades, A., Taber, L. H., Yow, M. D., Clark, D., Nathan, W.; Prolonged pneumococcal meningitis due to an organism with increased resistance to penicillin. Pediatrics 1976, 58: 378–381.

    PubMed  Google Scholar 

  40. Mace, J. W., Janik, D. S., Sauer, R. L., Quilligan, J. J.: Penicillin-resistant pneumococcal meningitis in an immunocpmpromised infant. Journal of Pediatrics 1977, 91: 506–507.

    PubMed  Google Scholar 

  41. Cates, K. L., Gerrard, J. M., Giebink, G. S., Lund, M. E., Bleeker, E. Z., Lau, S., O'Leary, M. C., Krivit, W., Quie, P. G.: A penicillin-resistant pneumococcus. Journal of Pediatrics 1978, 93: 624–626.

    PubMed  Google Scholar 

  42. Iyer, P. V., Kahler, J. H., Jacobs, N. M.: Penicillinresistant pneumococcal meningitis. Pediatrics 1978, 61: 157–158.

    PubMed  Google Scholar 

  43. Appelbaum, P. C., Bhamjee, A., Scragg, J. N., Hallett, A. F., Bowen, A. J., Cooper, R. C.:Streptococcus pneumoniae resistant to penicillin and chloramphenicol. Lancet 1977, ii: 995–997.

    Google Scholar 

  44. Jacobs, M. R., Koornhof, H. J., Robins-Btowne, R. M., Stevenson, C. M., Vermaak, Z. A., Freiman, I., Miller, G. B., Witcomb, M. A., Isaäcson, M., Ward, J. I., Austrian, R.: Emergence of multiply resistant pneumococci. New England Journal of Medicine 1978, 299: 735–740.

    PubMed  Google Scholar 

  45. Ward, J. I., Koornhof, H., Jacobs, M., Appelbaum, P.: Clinical and epidemiological features of multiply resistant pneumococci, South Africa. In: Schlessinger, D. (ed.): Microbiology — 1979. American Society for Microbiology, Washington, DC, 1979, p. 283–285.

    Google Scholar 

  46. Robins-Browne, R. M., Kharsany, A. B. M., Koornhof, H. J.: Antibiotic-resistant pneumococci in hospitalized children. Journal of Hygiene 1984, 93: 9–16.

    PubMed  Google Scholar 

  47. Klugman, K. P., Koornhof, H. J., Kuhnle, V., Miller, S. D., Ginsburg, P. J., Mauff, A. C.: Meningitis and pneumonia due to novel multiply resistant pneumococci. British Medical Journal 1986, i: 730.

    Google Scholar 

  48. Klugman, K. P., Koornhof, H. J.: Multiply resistant pneumococci in the community. In: Ishigami, J. (ed.): Recent advances in chemotherapy. Antimicrobial section I. Proceedings of the 14th International Congress of Chemotherapy. Tokyo University Press, Tokyo, 1985, p. 393–394.

    Google Scholar 

  49. Feldman, C., Kallenbach, J. M., Miller, S. D., Thorburn, J. R., Koornhof, H. J.: Community-acquired pneumonia due to penicillin-resistant pneumococci. New England Journal of Medicine 1985, 313: 615–617.

    PubMed  Google Scholar 

  50. Ahronheim, G. A., Reich, B., Marks, M. I.: Penicillininsensitive pneumococci. Case report and review. American Journal of Diseases of Children 1979, 133: 187–191.

    PubMed  Google Scholar 

  51. Michel, J., Dickman, D., Greenberg, Z., Bergner-Rabinowitz, S.: Serotype distribution of penicillinresistant pneumococci and their susceptibilities to seven antimicrobial agents. Antimicrobial Agents and Chemotherapy 1983, 23: 397–401.

    PubMed  Google Scholar 

  52. Casal, J.: Antimicrobial susceptibilityof Streptococcus pneumoniae: serotype distribution of penicillinresistant strains in Spain. Antimicrobial Agents and Chemotherapy 1982, 22: 222–225.

    PubMed  Google Scholar 

  53. Liñares, J., Garau, J., Domínguez, G, Pérez, J. L.: Antibiotic resistance and serotypes ofStreptococcus pneumonias from patients with community-acquired pneumococcal disease. Antimicrobial Agents and Chemotherapy 1983, 23: 545–547.

    PubMed  Google Scholar 

  54. Latorre, C., Juncosa, T., Sanfeliu, I.: Antibiotic resistance and serotypes of 100Streptococcus pneumoniae strains isolated in a children's hospital in Barcelona, Spain. Antimicrobial Agents and Chemotherapy 1985, 28: 357–359.

    PubMed  Google Scholar 

  55. Pérez, J. L., Liñares, J., Bosch, J., López de Goicoechea, M. J., Martín, R.: Antibiotic resistance ofStreptococcus pneumoniae in childhood carriers. European Journal of Clinical Microbiology 1986, 6: 278–280.

    Google Scholar 

  56. Modde, H. K.:Streptococcus pneumoniae isolates relatively insensitive to penicillin G recovered from patients in Switzerland. Chemotherapy 1978, 24: 227–230.

    PubMed  Google Scholar 

  57. Weber, F., Kayser, F. H.: Antimikrobielle Resistenz und Serotypen vonStreptococcus pneumoniae in der Schweiz. Schweizerische medizinische Wochenschrift 1979, 109: 395–399.

    PubMed  Google Scholar 

  58. Lund, E., Pulverer, G., Jeljaszewicz, J.: Serological types ofDiplococcus pneumoniae strains isolated in Germany. Comparison with type patterns in other countries. Medical Microbiology and Immunology 1974, 159: 171–178.

    Google Scholar 

  59. Milatović, D., Machka, K., Heck, W., Braveny, I.: Serotypes and antimicrobial susceptibility ofStreptococcus pneumoniae in West Germany. Infection 1981, 9: 220–222.

    PubMed  Google Scholar 

  60. Jeljaszewicz, J., Stochmal, I., Dajek, Z., Pulverer, G., Hryniewicz, W., Cybulska, J., Switalski, L. M., Dziarski, R.: Susceptibility ofStaphylococcus aureus, Streptococcus pyogenes andDiplococcus pneumoniae to antibiotics. Comparison of patterns in Poland and Federal Republic of Germany. Zentralblatt für Bakteriologie und Hygiene (A) 1976, 235: 376–385.

    Google Scholar 

  61. Ubukata, K., Takahashi, Y., Kon'nom, M.: Current status and antimicrobial susceptibility of pneumococci isolated from children with acute respiratory disease. Journal of Pediatric Practice 1975, 28: 1292–1297.

    Google Scholar 

  62. Oguri, T., Igari, J., Kosakai, N.: Antimicrobial susceptibility ofStreptococcus pneumoniae: serotype distribution of beta-lactam antibiotic resistant strains. In: Spitzy, K. H., Karrer, K. (ed.): Antibiotic resistance in vitro. Proceedings of the 13th International Congress of Chemotherapy SE 2.11/2, part 49. Verlag H. Egermann, Vienna, p. 49/8–49/11.

  63. Dixon, J. M. S., Lipinski, A. E., Graham, M. E. P.: Detection and prevalence of pneumococci with increased resistance to penicillin. Canadian Medical Association Journal 1977, 117: 1159–1161.

    PubMed  Google Scholar 

  64. Wall, R. A., Emmerson, A. M., Lamport, P.: Penicillinresistant pneumococci in London. Lancet 1981, ii: 148.

    Google Scholar 

  65. Koornhof, H. J., Jacobs, M., Isaacson, M., Appelbaum, P., Miller, B., Stevenson, C. M., Freeman, I., Nance, A., Botha, A., Glathaar, E., Gilliland, J.: Follow-up on multiple antibiotic-resistant pneumococci — South Africa. Morbidity and Mortality Weekly Report 1978, 27: 1–7.

    Google Scholar 

  66. Kislak, J. W., Razavi, L. M. B., Daly, A. K., Finland, M.: Susceptibility of pneumococci to nine antibiotics. American Journal of Medical Sciences 1965, 250: 261–268.

    Google Scholar 

  67. Tempest, B., Carney, J. P., Eberle, B.: Distribution of the sensitivities to penicillin of types ofDiplococcus pneumoniae in an American Indian population. Journal of Infectious Diseases 1974, 130: 67–69.

    PubMed  Google Scholar 

  68. Finland, M., Garner, C., Wilcox, C, Sabath, L. D.: Susceptibility of pneumococci andHaemophilus influenzae to antibacterial agents. Antimicrobial Agents and Chemotherapy 1976, 9: 274–287.

    PubMed  Google Scholar 

  69. Cooksey, R. C., Facklam, R. R., Thornsberry, C.: Antimicrobial susceptibility patterns ofStreptococcus pneumoniae. Antimicrobial Agents and Chemotherapy 1978, 13: 645–648.

    PubMed  Google Scholar 

  70. Gartner, J. C., Michaels, R. H.: Meningitis from a pneumococcus moderately resistant to penicillin. Journal of the American Medical Association 1979, 241: 1707–1709.

    PubMed  Google Scholar 

  71. Lauer, B. A., Relier, L. B.: Serotypes and penicillin susceptibility of pneumococci isolated from blood. Antimicrobial Agents and Chemotherapy 1980, 11: 242–244.

    Google Scholar 

  72. Maki, D. G., Helstad, A. G., Kimball, J. L.: Penicillin susceptibility ofStreptococcus pneumoniae in 1978. Screening for resistance by disk testing. American Journal of Clinical Pathology 1980, 73: 177–182.

    PubMed  Google Scholar 

  73. Saah, A. J., Mallonee, J. P., Tarpay, M., Thornsberry, C. T., Roberts, M. A., Rhoades, E. R.: Relative resistance to penicillin in the pneumococcus. A prevalence and case-control study. Journal of the American Medical Association 1980, 243: 1824–1827.

    Google Scholar 

  74. Anderson, K. C., Maurer, M. J., Dajani, A. S.: Pneumococci relatively resistant to penicillin: a prevalence survey in children. Journal of Pediatrics 1980, 97: 939–941.

    PubMed  Google Scholar 

  75. Radetsky, M. S., Istre, G. R., Johansen, T. L., Parmelee, S. W., Lauer, B. A., Wiesenthal, A. M., Glode, M. P.: Multiply resistant pneumococcus causing meningitis: its epidemiology within a day-care centre. Lancet 1981, ii: 771–773.

    Google Scholar 

  76. Krause, K. L., Stager, C., Gentry, L. O.: Prevalence of penicillin-resistant pneumococci in Houston, Texas. American Journal of Clinical Pathology 1982, 77: 210–213.

    PubMed  Google Scholar 

  77. Istre, G. R., Humphreys, J. T., Albrecht, K. D., Thornsberry, C., Swenson, J. M., Hopkins, R. S.: Chloramphenicol and penicillin resistance in pneumococci isolated from blood and cerebrospinal fluid: a prevalence study in metropolitan Denver. Journal of Clinical Microbiology 1983, 17: 472–475.

    PubMed  Google Scholar 

  78. Perlino, C. A., Lichtenberger, C. J.: Antibiotic susceptibility and serotype distribution ofStreptococcus pneumoniae. Stable incidence of antibiotic-resistant isolates and common serotypes. American Review of Respiratory Diseases 1984, 129: 1018–1020.

    Google Scholar 

  79. Jackson, M. A., Shelton, S., Nelson, J. D., McCracken, G. H.: Relatively penicillin-resistant pneumococcal infections in pediatric patients. Pediatric Infectious Disease 1984, 3: 129–132.

    PubMed  Google Scholar 

  80. Simberkoff, M. S., Lukaszewski, M., Cross, A., AlIbrahim, M., Balten, A. L., Smith, R. P., Geiseler, P. J., Nadler, J., Richmond, A. S.: Antibiotic-resistant isolates ofStreptococcus pneumoniae from clinical specimens: a cluster of serotype 19A organisms in Brooklyn, New York. Journal of Infectious Diseases 1986, 153: 78–82.

    PubMed  Google Scholar 

  81. Shope, T. C., Quie, P. G.:Diplococcus pneumoniae: increased resistance to oxacillin and cloxacillin. Minnesota Medicine 1968, 51: 37–38.

    PubMed  Google Scholar 

  82. Raymond, L., Kingsbury, D., Duncan, J. F.: Penicillin resistance ofDiplococcus pneumoniae in upper respiratory infections associated with diving. Aerospace Medicine 1971, 42: 196–198.

    PubMed  Google Scholar 

  83. Ward, J., Koornhof, H.: Antibiotic-resistant pneumococci. In: Remington, J. S., Swartz, M. N. (ed.): Current topics in infectious diseases. McGraw Hill, New York, 1980, p. 265–287.

    Google Scholar 

  84. Kootnhof, H. J., Jacobs, M. R., Ward, J. I., Appelbaum, P. C., Hallet, F. A.: Therapy and control of antibiotic-resistant pneumococcal disease. In: Schlessinger, D. (ed.): Microbiology — 1979. American Society for Microbiology, Washington, DC, 1979, p. 286–289.

    Google Scholar 

  85. Caputo, G. M., Sattler, F. R., Jacobs, M. R., Appelbaum, P. C.: Penicillin-resistant pneumococcus and meningitis. Annals of Internal Medicine 1983, 98: 416–417.

    PubMed  Google Scholar 

  86. Thornley, P. E., Aitken, J., Heffernan, H. M., Tobias, M. I.: Penicillin-resistantStreptococcus pneumoniae in New Zealand. New Zealand Medical Journal 1983, 96: 143–144.

    Google Scholar 

  87. Vâta, A., Turcu, T., Mihul, V., Cuciureanu, G., Scurtu, C., Baltiev, A., Radulescu, A.: Penicillin-resistantStreptococcus pneumoniae. Archives Roumaines de Pathologie Experimentale et de Microbiologie 1978, 36: 277–283.

    Google Scholar 

  88. Dublanchet, A., Durieux, R.: Isolement d'une souche deStreptococcus pneumoniae multirésistante aux antibiotiques. La Nouvelle Presse Médicale 1979, 8: 872.

    Google Scholar 

  89. Peyrefitte, F., Galland, A., Malhuret, C., Goldstein, F. W., Bouvet, A.: Les pneumocoques aussi sont résistants aux antibiotiques. La Nouvelle Presse Médicale 1979, 8: 872.

    Google Scholar 

  90. Hebert, J. P., Caillet, R.: Pneumocoques résistants aux antibiotiques. Une observation. La Nouvelle Presse Médicale 1980, 9: 1098–1099.

    Google Scholar 

  91. Wüst, J.: Zwei Stämme von Pneumokokken mit verminderter Penicillinempfindlichkeit in der Schweiz. Schweizerische Medizinische Wochenschrift 1985, 115: 555–557.

    PubMed  Google Scholar 

  92. Lapointe, J.-R., Joncas, J. H.: Meningitis in a Canadian infant due to pneumococcus resistant to penicillin and chloramphenicol. Journal of Pediatrics 1983, 103: 580–582.

    PubMed  Google Scholar 

  93. Robins-Browne, R. M., Gaspar, M. N., Ward, J. I., Wachsmuth, I. K., Koornhof, H. J., Jacobs, M. R., Thornsberry, C.: Resistance mechanisms of multiply resistant pneumococci: antibiotic degradation studies. Antimicrobial Agents and Chemotherapy 1979, 15: 470–474.

    PubMed  Google Scholar 

  94. Zighelboim, S., Tomasz, A.: Stepwise acquisition of resistance to oxacillin inStreptococcus pneumoniae. In: Schlessinger, D. (ed.): Microbiology — 1979. American Society for Microbiology, Washington, DC, 1979, p. 290–292.

    Google Scholar 

  95. Zighelboim, S., Tomasz, A.: Penicillin-binding proteins of multiply antibiotic-resistant South African strains ofStreptococcus pneumoniae. Antimicrobial Agents and Chemotherapy 1980, 17: 434–442.

    PubMed  Google Scholar 

  96. Zighelboim, S., Tomasz, A.: Multiple antibiotic resistance in South African strains ofStreptococcus pneumoniae: mechanism of resistance toβ-lactam antibiotics. Reviews of Infectious Diseases 1981, 3: 267–276.

    PubMed  Google Scholar 

  97. Handwerger, S., Tomasz, A.: Alterations in penicillinbinding proteins of clinical and laboratory isolates of pathogenicStreptococcus pneumoniae with low levels of penicillin resistance. Journal of Infectious Diseases 1986, 153: 83–89.

    PubMed  Google Scholar 

  98. Handwerger, S., Tomasz, A.: Alterations in kinetic properties of penicillin-binding proteins of penicillinresistantStreptococcus pneumoniae. Antimicrobial Agents and Chemotherapy 1986, 30: 57–63.

    PubMed  Google Scholar 

  99. Hakenbeck, R., Ellerbrok, H., Briese, T., Handwerger, S., Tomasz, A.: Penicillin-binding proteins of penicillinsusceptible and -resistant pneumococci: immunological relatedness of altered proteins and changes in peptides carrying theβ-lactam binding site. Antimicrobial Agents and Chemotherapy 1986, 30: 553–558.

    PubMed  Google Scholar 

  100. Liu, H. H., Tomasz, A.: Penicillin tolerance in multiply drug-resistant natural isolates ofStreptococcus pneumoniae. Journal of Infectious Diseases 1985, 152: 365–372.

    PubMed  Google Scholar 

  101. Jacobs, M. R., Mithal, Y., Robins-Browne, R. M., Caspar, M. N., Koornhof, H. J.: Antimicrobial susceptibility testing of pneumococci: determination of Kirby-Bauer breakpoints for penicillin G, erythromycin, clindamycin, tetracycline, chloramphenicol, and rifampin. Antimicrobial Agents and Chemotherapy 1979, 16: 190–197.

    PubMed  Google Scholar 

  102. Jacobs, M. R., Gaspar, M. N., Robins-Browne, R. M., Koornhof, H. J.: Antimicrobial susceptibility testing of pneumococci. 2. Determination of optimal disc diffusion test for detection of penicillin G resistance. Journal of Antimicrobial Chemotherapy 1980, 6: 53–64.

    PubMed  Google Scholar 

  103. National Committee for Clinical Laboratory Standards: Performance standards for antimicrobial disk susceptibility tests, M2-A3. NCCLS, Villanova, PA, 1986.

    Google Scholar 

  104. Swenson, J. M., Hill, B. C., Thornsberry, C.: Screening pneumococci for penicillin resistance. Antimicrobial Agents and Chemotherapy 1986, 24: 749–752.

    Google Scholar 

  105. Tarpay, M. M., Welch, D. F., Marks, M. I.: Antimicrobial susceptibility testing ofStreptococcus pneumoniae by micro-broth dilution. Antimicrobial Agents and Chemotherapy 1980, 18: 579–581.

    PubMed  Google Scholar 

  106. Shanholtzer, C. J., Peterson, L. R.: False susceptible penicillin G MICs forStreptococcus pneumoniae with a commercial microdilution system. American Journal of Clinical Pathology 1986, 85: 626–629.

    PubMed  Google Scholar 

  107. Jones, R. N., Edson, D. C., CAP Microbiology Resourc e Committee: The ability of participant laboratories to detect penicillin-resistant pneumococci. A report from the microbiology portion of the College of American Pathologists (CAP) surveys. American Journal of Clinical Pathology 1982, 78, Supplement: 659–663.

    PubMed  Google Scholar 

  108. Jones, R. N., Edson, D. C., CAP Microbiology Resource Committee: Special topics in antimicrobial susceptibility testing: test accuracy against methicillin-resistantStaphylococcus aureus, pneumococci, and the sensitivity ofβ-lactamase methods. American Journal of Clinical Pathology 1983, 80, Supplement: 609–614.

    PubMed  Google Scholar 

  109. Decker, M. D., Gregory, D. W., Boldt, J., Hutcheson, R. H., Schaffner, W.: The detection of penicillin-resistant pneumococci. The compliance of hospital laboratories with recommended methods. American Journal of Clinical Pathology 1985, 84: 357–360.

    PubMed  Google Scholar 

  110. Landesman, S. H., Cummings, M., Gruarin, A., Bernheimer, H.: Susceptibility of multiply antibioticresistant pneumococci to the new beta-lactam drugs and rosaramicin. Antimicrobial Agents and Chemotherapy 1981, 19: 675–677.

    PubMed  Google Scholar 

  111. Ward, J. L., Moellering, R. C.: Susceptibility of pneumococci to 14 beta-lactam agents: comparison of strains resistant, intermediate-resistant, and susceptible to penicillin. Antimicrobial Agents and Chemotherapy 1981, 20: 204–207.

    PubMed  Google Scholar 

  112. Tarpay, M. M., Welch, D. F., Marks, M. I.: In vitro activity of moxalactam and cefoperazone againstStreptococcus pneumoniae with differing susceptibilities to penicillin. Chemotherapy 1982, 28: 261–266.

    PubMed  Google Scholar 

  113. Tweardy, D. J., Jacobs, M. R., Speck, W. T.: Susceptibility of penicillin-resistant pneumococci to eighteen antimicrobials: implications for treatment of meningitis. Journal of Antimicrobial Chemotherapy 1983, 12: 133–139.

    Google Scholar 

  114. Linares, J., Perez, J. L., Garau, J., Murgui, L., Martín, R.: Comparative susceptibilities of penicillin-resistant pneumococci to co-trimoxazole, vancomycin, rifampicin and fourteenβ-lactam antibiotics. Journal of Antimicrobial Chemotherapy 1984, 13: 353–359.

    PubMed  Google Scholar 

  115. Beam, T. R.: Vancomycin therapy of experimental pneumococcal meningitis caused by penicillin-sensitive and resistant strains. Journal of Antimicrobial Chemotherapy 1981, 7: 89–99.

    PubMed  Google Scholar 

  116. Buzón, L. M., Guerrero, A., Romero, J., Santamaria, J. M., Bouza, E.: Penicillin-resistantStreptococcus pneumoniae meningitis successfully treated with vancomycin. European Journal of Clinical Microbiology 1984, 3: 442–443.

    PubMed  Google Scholar 

  117. Lecour, H., Seara, A., Miranda, A. M., Cordeiro, J.: Cefotaxime in pneumococcal meningitis. Infection 1985, 13, Supplement: S73-S75.

    PubMed  Google Scholar 

  118. McCracken, G. H., Jr., Sakata, Y.: Antimicrobial therapy of experimental meningitis caused byStreptococcus pneumoniae strains with different susceptibilities to penicillin. Antimicrobial Agents and Chemotherapy 1985, 27: 141–145.

    PubMed  Google Scholar 

  119. Tarpay, M. M., Welch, D. F., Salari, H., Marks, M. I.: In vitro activity of antibiotics commonly used in the treatment of otitis media againstStreptococcus pneumoniae isolates with different susceptibilities to penicillin. Antimicrobial Agents and Chemotherapy 1982, 22: 145–147.

    PubMed  Google Scholar 

  120. Gombert, M. E., Aulicino, T. M.: Susceptibility of multiply antibiotic-resistant pneumococci to the new quinolone antibiotics, nalidixic acid, coumermycin, and novobiocin. Antimicrobial Agents and Chemotherapy 1984, 26: 933–934.

    PubMed  Google Scholar 

  121. Eliopoulos, G. M., Moellering, A. E., Reiszner, E., Moellering, R. C.: In vitro activities of the quinolone antimicrobial agents A-56619 and A-56620. Antimicrobial Agents and Chemotherapy 1985, 28: 514–520.

    PubMed  Google Scholar 

  122. Eliopoulos, G. M., Willey, S., Reiszner, E., Spitzer, P. G., Caputo, G., Moellering, R. C.: In vitro and in vivo activity of LY 146032, a new cyclic lipopeptide antibiotic. Antimicrobial Agents and Chemotherapy 1986, 30: 532–535.

    PubMed  Google Scholar 

  123. Kamimura, T., Kojo, H., Matsumoto, Y., Mine, Y., Goto, S., Kuwahara, S.: In vitro and in vivo antibacterial properties of FK 027, a new orally active cephem antibiotic. Antimicrobial Agents and Chemotherapy 1984, 25: 98–104.

    PubMed  Google Scholar 

  124. Verbist, L., Tjandramaga, B., Hendrickx, B., van Hecken, A., van Meile, P., Verbesselt, R., Verhaegen, J., DeSchepper, P. J.: In vitro activity and human pharmacokinetics of teicoplanin. Antimicrobial Agents and Chemotherapy 1984, 26: 881–886.

    PubMed  Google Scholar 

  125. Fuchs, P. C., Jones, R. N., Barry, A. L., Thornsberry, C.: Evaluation of the in vitro activity of BMY-28142, a new broad-spectrum cephalosporin. Antimicrobial Agents and Chemotherapy 1985, 27: 679–682.

    PubMed  Google Scholar 

  126. Wolfson, J. S., Hooper, D. C.: The fluoroquinolones: structures, mechanisms of action and resistance, and spectra of activity in vitro. Antimicrobial Agents and Chemotherapy 1985, 28: 581–586.

    PubMed  Google Scholar 

  127. Barry, A. L., Thornsberry, C., Jones, R. N.: In vitro activity of a new macrolide, A-56268, compared with that of roxithromycin, erythromycin, and clindamycin. Antimicrobial Agents and Chemotherapy 1987, 31: 343–345.

    PubMed  Google Scholar 

  128. Chau, P. Y., Leung, Y. K., Ng, W. W. S., Arnold, K.: Comparative in vitro antibacterial activities of two new oral cephalosporins, ceftetrame (RO 19-5247) and cefetamet (RO 15-8074). Antimicrobial Agents and Chemotherapy 1987, 31: 473–476.

    PubMed  Google Scholar 

  129. Chin, N.-X., Neu, H. C.: Comparative antibacterial activity of a new oral cephalosporin, BMY-28100. Antimicrobial Agents and Chemotherapy 1987, 31: 480–483.

    PubMed  Google Scholar 

  130. Rolston, K. V. I., LeBlanc, B., Ho, D. H., Bodey, G. P.: In vitro activity of paldimycin (U-70138F) against gram-positive bacteria isolated from patients with cancer. Antimicrobial Agents and Chemotherapy 1987, 31: 650–652.

    PubMed  Google Scholar 

  131. Neu, H. C., Chin, N.-X.: In-vitro activity of two new quinolone antimicrobial agents, S-25930 and S-2S932 compared with that of other agents. Journal of Antimicrobial Chemotherapy 1987, 19: 175–185.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pathology, Hershey Medical Center, PO Box 850, 17033, Hershey, Pennsylvania, USA

    P. C. Appelbaum

Authors
  1. P. C. Appelbaum
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Appelbaum, P.C. World-wide development of antibiotic resistance in pneumococci. Eur. J, Clin. Microbiol. 6, 367–377 (1987). https://doi.org/10.1007/BF02013089

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02013089

Keywords

Search

Navigation